Clinical Trial Update: Curcumin Biomarker Trial in Head and Neck Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 curcumin biomarker trial for head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: Louisiana State University Health Sciences Center Shreveport | Conditions: Head and Neck Cancer | EARLY_Phase 1 | Status: COMPLETED